What are the first‑line topical treatments for osteoarthritis‑related joint pain?

First-Line Topical Treatment for Osteoarthritis Joint Pain

Topical NSAIDs, specifically topical diclofenac gel, are the first-line topical treatment for knee osteoarthritis, and should be used before oral NSAIDs due to markedly reduced systemic toxicity while providing equivalent pain relief. 1, 2, 3

Treatment Algorithm by Joint Location

Knee Osteoarthritis

• Start with topical NSAIDs (diclofenac gel) as first-line pharmacological treatment, strongly recommended by the American College of Rheumatology/Arthritis Foundation and supported by NICE and EULAR guidelines 1, 2, 4
• Apply topical diclofenac at the affected knee twice daily for at least 4 weeks to assess efficacy 5
• Topical diclofenac delivers effective drug concentrations to the joint with minimal systemic absorption, avoiding gastrointestinal bleeding, cardiovascular events, and renal toxicity that plague oral NSAIDs 6, 4
• If topical NSAIDs provide insufficient relief after 4 weeks, consider topical capsaicin as a second-line topical option (conditionally recommended), though it requires 2-4 weeks of continuous use before therapeutic benefit and causes local burning sensations 1, 2, 3
• Topical ketoprofen gel is an evidence-based alternative to diclofenac, showing 63% response rates versus 48% with placebo in chronic osteoarthritis 7

Hand Osteoarthritis

• Topical NSAIDs are conditionally recommended (weaker recommendation than for knee) due to practical considerations like frequent hand washing and less direct evidence 1, 2, 1
• Topical capsaicin is conditionally recommended AGAINST for hand OA due to lack of direct evidence and increased risk of accidental eye contamination 1, 2

Hip Osteoarthritis

• Do not use topical NSAIDs or capsaicin for hip OA - the depth of the hip joint beneath the skin surface makes topical agents unlikely to provide meaningful benefit 1, 2, 3

Critical Safety Advantages of Topical NSAIDs

• Pooled safety data shows similar low adverse event rates in high-risk patients (age ≥65 years, hypertension, diabetes, cardiovascular disease) compared to low-risk patients 6, 4
• Topical NSAIDs have markedly fewer gastrointestinal adverse events compared to oral NSAIDs, while having substantially more local skin reactions (which are generally mild) 3, 8
• Safety profile remains consistent at 1 year, not just the typical 12-week study duration 3
• Minimal systemic absorption means negligible platelet dysfunction risk and acceptable use in patients with renal impairment, where oral NSAIDs are contraindicated 6

When Topical Treatment Fails

• Only escalate to oral NSAIDs after topical treatments have failed, using the lowest effective dose for the shortest possible duration 7, 4
• Always co-prescribe a proton pump inhibitor for gastroprotection when using oral NSAIDs 7, 6, 4
• Consider intra-articular corticosteroid injections for moderate to severe pain when topical and oral analgesics provide insufficient relief 7

Common Pitfalls to Avoid

• Do not prescribe topical lidocaine preparations - insufficient data exists to support their use in OA 1, 2
• Do not recommend glucosamine, chondroitin, or hyaluronic acid injections - these lack clinically important outcomes compared to placebo 7, 6
• Do not use topical salicylates (rubefacients) - they are not recommended for osteoarthritis 7
• Avoid premature escalation to oral NSAIDs before giving topical agents an adequate 4-week trial 4, 5